What is the current valuation of the US multiplex assays market?

The market valuation was $645.73 Million in 2024. Read More

What is the projected market size for the US multiplex assays market by 2035?

The market is expected to reach $1342.34 Million by 2035. Read More

What is the expected CAGR for the US multiplex assays market during the forecast period 2025 - 2035?

The expected CAGR is 6.88% during the forecast period. Read More

Which application segment had the highest valuation in 2024?

The Clinical Diagnostics segment had the highest valuation at $400.0 Million in 2024. Read More

What are the key technologies driving the US multiplex assays market?

Key technologies include Luminex xMAP Technology and Magnetic Bead-Based Assays, with valuations of $210.0 Million and $250.0 Million, respectively. Read More

Which platform segment is projected to grow the most by 2035?

The Cell-Based Platforms segment, valued at $442.34 Million, is projected to grow significantly by 2035. Read More

Who are the leading companies in the US multiplex assays market?

Key players include Thermo Fisher Scientific, Abbott Laboratories, and Roche Diagnostics. Read More

What end-user segment is expected to dominate the market by 2035?

Pharmaceutical Companies, with a projected valuation of $442.34 Million, are expected to dominate the market. Read More

How does the Food Safety Testing segment compare to others in 2024?

The Food Safety Testing segment was valued at $200.0 Million in 2024, indicating strong performance. Read More

What is the significance of the Nucleic Acid Platforms in the market?

Nucleic Acid Platforms, valued at $400.0 Million, play a crucial role in the growth of the multiplex assays market. Read More

US Multiplex Assays Market

US Multiplex Assays Market Research Report: Size, Share, Trend Analysis By Applications (Clinical Diagnostics, Drug Discovery, Environmental Testing, Food Safety Testing, Genetic Research), By Technology (Luminex xMAP Technology, Magnetic Bead-Based Assays, Flow Cytometry, PCR, ELISA), By Platform (Microarray Platforms, Nucleic Acid Platforms, Protein Platforms, Cell-Based Platforms) and By End Users (Hospitals, Laboratories, Research Institutions, Pharmaceutical Companies) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

6.88%

2024 Market Size

$ 645.73 Million

2035 Market Size

$ 1,342.34 Million

Healthcare ● Updated April 2026 Report ID: MRFR/HC/16447-HCR | Pages: 100 | Author: Nidhi Mandole, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Application (USD Million)
  1. 4.1.1 Clinical Diagnostics
  2. 4.1.2 Drug Discovery
  3. 4.1.3 Environmental Testing
  4. 4.1.4 Food Safety Testing
  5. 4.1.5 Genetic Research
2. 4.2 Medical Device, BY Technology (USD Million)
  1. 4.2.1 Luminex xMAP Technology
  2. 4.2.2 Magnetic Bead-Based Assays
  3. 4.2.3 Flow Cytometry
  4. 4.2.4 PCR (Polymerase Chain Reaction)
  5. 4.2.5 ELISA (Enzyme-Linked Immunosorbent Assay)
3. 4.3 Medical Device, BY Platform (USD Million)
  1. 4.3.1 Microarray Platforms
  2. 4.3.2 Nucleic Acid Platforms
  3. 4.3.3 Protein Platforms
  4. 4.3.4 Cell-Based Platforms
4. 4.4 Medical Device, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Laboratories
  3. 4.4.3 Research Institutions
  4. 4.4.4 Pharmaceutical Companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abbott Laboratories (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Roche Diagnostics (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Agilent Technologies (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bio-Rad Laboratories (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Merck KGaA (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 PerkinElmer (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Luminex Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Qiagen N.V. (NL)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 US MARKET ANALYSIS BY PLATFORM
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY TECHNOLOGY, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY PLATFORM, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY PLATFORM, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY PLATFORM, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Multiplex Assays Market Segmentation

US Multiplex Assays Market By Application (USD Million, 2025-2035)

Clinical Diagnostics
Drug Discovery
Environmental Testing
Food Safety Testing
Genetic Research

US Multiplex Assays Market By Technology (USD Million, 2025-2035)

Luminex xMAP Technology
Magnetic Bead-Based Assays
Flow Cytometry
PCR (Polymerase Chain Reaction)
ELISA (Enzyme-Linked Immunosorbent Assay)

US Multiplex Assays Market By Platform (USD Million, 2025-2035)

Microarray Platforms
Nucleic Acid Platforms
Protein Platforms
Cell-Based Platforms

US Multiplex Assays Market By End User (USD Million, 2025-2035)

Hospitals
Laboratories
Research Institutions
Pharmaceutical Companies

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”